"Nothing comes without a downside. These molecules do produce significant nausea and vomiting in some people — to the extent that they have to discontinue the medication. Some may develop diarrhoea, some may have severe constipation. Others may not like the way they lose weight—they may feel very shrunken or their face may seem very thinned out. Thats another sort of downside," says Dr Ambrish Mithal, chairman, endocrinology & diabetes, Max Healthcare, Delhi.
Pune-based Serum Institute of India (SII) is prepared to increase production of injectable poliomyelitis vaccine (IPV) to fill the gap left by France s Sanofi closing its manufacturing plants in India. SII currently supplies half of the 20 million IPV doses to the government s immunization program and can provide additional doses with a 3-4 month notice. Adar Poonawalla, SII CEO, stated that supplying IPV to the government at current prices is unviable for most companies, but SII continues to do so as a service to the nation.
US drug maker Eli Lilly plans to launch its weight-loss drugs Zepbound and Mounjaro in India next year. The company is considering pricing based on supply and volume expansion. Eli Lilly CEO David Ricks suggests focusing on digital services in the Indian healthcare industry to encourage innovation and improve access to healthcare.
At a market cap that exceeds $720 billion, US drug maker Eli Lilly tops the list of worlds most valuable pharmaceutical companies. The key to that is recent US approval for its weight-loss drug Zepbound (tirzepatide).
India s young adults are breaking taboos by seeking help for depression, anxiety, and stress. This is a positive step, but the surge in antidepressant use and "cool" mental health merch raises questions. Are we normalizing panic attacks? What s driving this surge in mental health issues? Academic pressure, social media, or deeper societal issues? Even students as young as 7 are battling depression and anxiety. What are schools doing about this? Host Ratna Bhushan talks to Geetika Kapoor, School Psychologist and founder of EdEssential, Ayesha Syal, Senior Faculty and Lead Educator, St Xaviers School, along with ET’s in-house expert Teena Thacker. Listen to the latest episode of The Morning Brief podcast! Credit: Abhi and Niyu, ABC News (Australia) and Indiatimes.